Filings & corporate actions
- 4 NovresultsResults · Q2 FY27 · consolidated and standalone-1.7%NSE
- 8 OctshareholdingShareholding · 30 Sept 2026-4.7%NSE
- 22 SeptdividendDividend · ₹0.40 per share · record 22 Sept 2026+3.6%
- 31 JulresultsResults · Q1 FY27 · consolidated and standalone-2.8%NSE
- 10 JulshareholdingShareholding · 30 Jun 2026-1.1%NSE
- 22 MayresultsResults · Q4 FY26 · consolidated and standalone-3.2%NSE
- 16 AprshareholdingShareholding · 31 Mar 2026-3.2%NSE
- 7 FebresultsResults · Q3 FY26 · consolidated and standalone+0.7%NSE
- 9 JanshareholdingShareholding · 31 Dec 2025-1.3%NSE
Reaction to results · all yearsrose on day 0 in 33 of 79 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 4 Nov 2026 | -1.7% | -0.3% | — | 1.1× |
| Q1 FY27 | 31 Jul 2026 | -2.8% | -0.5% | -0.5% | 1.4× |
| Q4 FY26 | 22 May 2026 | -3.2% | -4.6% | -0.3% | 2.6× |
| Q3 FY26 | 7 Feb 2026 | +0.7% | +7.0% | +32.2% | 2.4× |
| Q2 FY26 | 8 Nov 2025 | +1.3% | +0.3% | +10.6% | 34.1× |
| Q1 FY26 | 9 Aug 2025 | +2.4% | +6.4% | +19.5% | 2.0× |
| Q4 FY25 | 30 May 2025 | -1.8% | -5.5% | -5.3% | 2.2× |
| Q3 FY25 | 12 Feb 2025 | -3.1% | -3.8% | -10.6% | 1.8× |
| Q2 FY25 | 8 Nov 2024 | -5.0% | -15.3% | -14.4% | 1.6× |
| Q1 FY25 | 5 Aug 2024 | -9.9% | -9.7% | +9.9% | 2.3× |
| Q4 FY24 | 29 May 2024 | -6.1% | -7.0% | +5.5% | 2.7× |
| Q3 FY24 | 8 Feb 2024 | +11.9% | +14.0% | +36.8% | 44.3× |
| Q2 FY24 | 8 Nov 2023 | -2.1% | -2.4% | -2.8% | 1.4× |
| Q1 FY24 | 8 Aug 2023 | +3.1% | +2.0% | +1.0% | 1.8× |
| Q4 FY23 | 24 May 2023 | +0.9% | 0.0% | +10.0% | 1.6× |
| Q3 FY23 | 9 Feb 2023 | +3.6% | -4.6% | -5.2% | 5.5× |
| Q2 FY23 | 12 Nov 2022 | -13.9% | -22.0% | -20.8% | 5.8× |
| Q1 FY23 | 13 Aug 2022 | -6.2% | -8.1% | +5.2% | 4.4× |
| Q4 FY22 | 30 May 2022 | -3.1% | -1.0% | -3.4% | 3.4× |
| Q3 FY22 | 9 Feb 2022 | -4.6% | -10.9% | -16.7% | 1.2× |
| Q2 FY22 | 12 Nov 2021 | -1.9% | -4.8% | -9.1% | 2.2× |
| Q1 FY22 | 7 Aug 2021 | -3.3% | -7.2% | -14.1% | 1.1× |
| Q4 FY21 | 30 May 2021 | +0.8% | -3.8% | +5.8% | 1.4× |
| Q3 FY21 | 11 Feb 2021 | +3.5% | +0.2% | 0.0% | 3.1× |
| Q2 FY21 | 4 Nov 2020 | -1.8% | +2.4% | +14.8% | 0.5× |
| Q1 FY21 | 12 Aug 2020 | +2.6% | -3.6% | -12.6% | 0.7× |
| Q4 FY20 | 6 Jun 2020 | -1.4% | +26.4% | +44.4% | 3.3× |
| Q3 FY20 | 13 Feb 2020 | -3.6% | -5.3% | -27.2% | 1.6× |
| Q2 FY20 | 13 Nov 2019 | +3.2% | +1.9% | -0.1% | 2.3× |
| Q1 FY20 | 13 Aug 2019 | -1.8% | -5.9% | +4.2% | 1.6× |
| Q4 FY19 | 28 May 2019 | +3.4% | -0.9% | -9.4% | 6.3× |
| Q3 FY19 | 28 Feb 2019 | +0.3% | +3.0% | -0.2% | 1.4× |
| Q2 FY19 | 22 Nov 2018 | +0.4% | +0.1% | -4.0% | 0.5× |
| Q1 FY19 | 2 Aug 2018 | +2.0% | -4.2% | +11.7% | 1.7× |
| Q4 FY18 | 21 Jun 2018 | -1.7% | -1.4% | -11.2% | 0.2× |
| Q3 FY18 | 22 Feb 2018 | -0.6% | -3.6% | -17.6% | 0.6× |
| Q2 FY18 | 18 Dec 2017 | +0.6% | +3.2% | +1.6% | 0.4× |
| Q1 FY18 | 21 Sept 2017 | +0.4% | -4.2% | -7.2% | 10.0× |
| Q4 FY17 | 10 Jun 2017 | +0.4% | +1.7% | +2.6% | 0.3× |
| Q3 FY17 | 13 Feb 2017 | -1.4% | -3.2% | -6.2% | 0.5× |
| Q2 FY17 | 7 Nov 2016 | +2.4% | -10.0% | -6.5% | 0.6× |
| Q1 FY17 | 13 Aug 2016 | -2.1% | +3.7% | +2.4% | 0.2× |
| Q4 FY16 | 16 May 2016 | +0.9% | -5.2% | +1.9% | 0.8× |
| Q3 FY16 | 12 Feb 2016 | +1.3% | -4.4% | +5.5% | 1.1× |
| Q2 FY16 | 9 Nov 2015 | -0.3% | +3.0% | +14.1% | 0.6× |
| Q1 FY16 | 11 Aug 2015 | -6.3% | -5.1% | -19.1% | 1.2× |
| Q4 FY15 | 4 Jun 2015 | -0.6% | -0.7% | +6.3% | 0.6× |
| Q3 FY15 | 10 Feb 2015 | +0.7% | +2.1% | +11.8% | 0.5× |
| Q2 FY15 | 18 Nov 2014 | -0.6% | -5.5% | -9.4% | 0.7× |
| Q1 FY15 | 14 Aug 2014 | +0.7% | -1.2% | +26.1% | 1.2× |
| Q4 FY14 | 7 Jun 2014 | +0.5% | -3.1% | +24.7% | 0.9× |
| Q3 FY14 | 12 Feb 2014 | +4.6% | +15.6% | +16.8% | 0.4× |
| Q2 FY14 | 22 Nov 2013 | -1.8% | -4.8% | +16.7% | 0.1× |
| Q1 FY14 | 19 Aug 2013 | -3.3% | -8.8% | -3.6% | 0.0× |
| Q4 FY13 | 20 Jun 2013 | -10.4% | -10.8% | -17.7% | 3.4× |
| Q3 FY13 | 20 Feb 2013 | +0.7% | +8.4% | -3.1% | 2.6× |
| Q2 FY13 | 16 Nov 2012 | +0.5% | +1.6% | -0.5% | 0.0× |
| Q1 FY13 | 13 Aug 2012 | -0.3% | +4.7% | +4.4% | 0.2× |
| Q4 FY12 | 11 May 2012 | -4.7% | -6.3% | -10.3% | 0.4× |
| Q3 FY12 | 20 Feb 2012 | -0.6% | +0.3% | -9.1% | 2.0× |
| Q2 FY12 | 2 Nov 2011 | +0.3% | +0.9% | -8.5% | 1.5× |
| Q1 FY12 | 8 Aug 2011 | -7.1% | -7.4% | -13.2% | 0.6× |
| Q4 FY11 | 12 May 2011 | -1.0% | -1.0% | +4.1% | 0.3× |
| Q3 FY11 | 29 Jan 2011 | -0.8% | -0.5% | -3.7% | 0.4× |
| Q2 FY11 | 1 Nov 2010 | +0.5% | +2.4% | +3.4% | 0.9× |
| Q1 FY11 | 23 Jul 2010 | -0.3% | +3.6% | +11.4% | 3.1× |
| Q4 FY10 | 12 May 2010 | +0.6% | -2.6% | -2.9% | 0.2× |
| Q3 FY10 | 30 Jan 2010 | +1.0% | 0.0% | +5.9% | 0.4× |
| Q2 FY10 | 28 Oct 2009 | -2.8% | -3.5% | -5.2% | 0.1× |
| Q1 FY10 | 25 Jul 2009 | -3.5% | +0.4% | +8.8% | 0.5× |
| Q4 FY09 | 30 Apr 2009 | 0.0% | +0.5% | +55.4% | 9.9× |
| Q3 FY09 | 27 Jan 2009 | -2.0% | +0.7% | -2.0% | 0.3× |
| Q2 FY09 | 1 Nov 2008 | -3.3% | -2.9% | -25.4% | 1.5× |
| Q1 FY09 | 30 Jul 2008 | -0.4% | -1.8% | -6.3% | 3.1× |
| Q4 FY08 | 30 Apr 2008 | +3.1% | +11.7% | +36.1% | 1.5× |
| Q3 FY08 | 31 Jan 2008 | -2.0% | -3.6% | -9.9% | 0.4× |
| Q2 FY08 | 29 Oct 2007 | -1.4% | -2.8% | -2.0% | 1.5× |
| Q1 FY08 | 30 Jul 2007 | -3.3% | -8.7% | -13.4% | 3.5× |
| Q4 FY07 | 30 Apr 2007 | +1.9% | +8.4% | +5.6% | 0.9× |
| Average | -1.0% | -1.4% | +1.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +12.4% | +17.4% | +24.4% | +8.1% | +15.0% | — |
| Profit | +40.6% | +55.7% | +189.5% | +5.3% | +24.2% | — |
Key data
Delivery percentage
Over the last 20 sessions SMSPHARMA settled 40.5% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 42.2%. The latest session ranks higher than 36% of the 3,527 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -1.68% | -6.85% | +10.40% | +32.75% | +11.13% | +65.88% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 210.4 | 237.9 | 207.0 | 316.1 |
| YoY chg | +21.4% | -4.1% | +5.6% | +30.4% |
| Net profit (₹ Cr) | 23.5 | 32.7 | 20.9 | 39.9 |
| YoY chg | +28.7% | +61.0% | +2.0% | +57.4% |
| Net margin | 11.2% | 13.7% | 10.1% | 12.6% |
| EPS | 2.59 | 3.58 | 2.23 | 4.26 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 68.07% · public 31.93%- Promoter
- Public and others
- Promoter
- 68.07%
- Public
- 31.93%
- Promoter change
- 0.00 pp
- Filed
- 8 Oct 2026
- FII
- 1.18%
- DII
- 0.20%
- Promoter pledged
- 17.99%
Who the public is
- Mutual funds
- 0.00%
- Insurance
- 0.00%
- FPI
- 1.18%
- Retail ≤ ₹2L
- 18.35%
- HNI > ₹2L
- 7.50%
- NRI
- 2.16%
- Bodies corporate
- 1.85%
- Shareholders
- 34,904
-2.81 pp QoQ
0.00 pp QoQ
+0.53 pp QoQ
+0.89 pp QoQ
+0.92 pp QoQ
-0.15 pp QoQ
+0.44 pp QoQ
+10.8% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| RAMESH BABU POTLURI | Promoter · Individual | 19.38% | 1.82Cr |
| VAMSI KRISHNA POTLURI | Promoter · Individual | 16.90% | 1.58Cr |
| HIMA BINDU POTLURI | Promoter · Individual | 16.03% | 1.50Cr |
| POTLURI INFRA PROJECTS LLP | Promoter · Corporate | 9.45% | 88.46L |
| TRILOK POTLURI | Promoter · Individual | 5.01% | 46.88L |
| ANIRUDDH MUNDRA | Individual | 1.84% | 17.22L |
| Venkata Subbaraju Penmatsa HUF | Individual | 1.60% | 15.00L |
| ALPANA MUNDRA | Individual | 1.50% | 14.04L |
| VENKATA PRAVEEN TALLURI | Individual | 1.41% | 13.20L |
| SUDEEPTHI GOPINEEDI | Individual | 1.41% | 13.20L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹0.40 | ₹0.40 |
| FY2025-26 | 1 | ₹0.40 | ₹0.40 |
| FY2024-25 | 1 | ₹0.40 | ₹0.40 |
| FY2023-24 | 1 | ₹0.30 | ₹0.30 |
| FY2022-23 | 1 | ₹0.30 | ₹0.30 |
| FY2021-22 | 1 | ₹0.30 | ₹0.30 |
| FY2019-20 | 2 | ₹0.50 | ₹0.50 |
| FY2018-19 | 1 | ₹0.25 | ₹0.25 |
| FY2017-18 | 1 | ₹0.20 | ₹0.20 |
| FY2016-17 | 1 | ₹0.20 | ₹0.20 |
| FY2015-16 | 1 | ₹2.00 | ₹0.20 |
| FY2014-15 | 1 | ₹2.00 | ₹0.20 |
| FY2013-14 | 1 | ₹2.00 | ₹0.20 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 22 Sept 2026 | 22 Sept 2026 | ₹0.40 | ₹0.40 |
| 22 Sept 2025 | — | ₹0.40 | ₹0.40 |
| 23 Sept 2024 | — | ₹0.40 | ₹0.40 |
| 22 Sept 2023 | — | ₹0.30 | ₹0.30 |
| 22 Sept 2022 | — | ₹0.30 | ₹0.30 |
| 22 Sept 2021 | — | ₹0.30 | ₹0.30 |
| 26 Mar 2020 | — | ₹0.25 | ₹0.25 |
| 19 Sept 2019 | — | ₹0.25 | ₹0.25 |
| 11 Sept 2018 | — | ₹0.25 | ₹0.25 |
| 20 Sept 2017 | — | ₹0.20 | ₹0.20 |
| 22 Sept 2016 | — | ₹0.20 | ₹0.20 |
| 22 Sept 2015 | — | ₹2.00 | ₹0.20 |
| 23 Sept 2014 | — | ₹2.00 | ₹0.20 |
| 23 Sept 2013 | — | ₹2.00 | ₹0.20 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 3.4 years ago
- Disclosures on record
- 62
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | POTLURU JHANSILAXMIRelative | Sell | 2.0K | ₹10.5L | 527.00 | 20.9K → 18.9K | 0.02%-0.00 pp | 7(2)told 12 Nov 2026 |
| 21 Sept 2026 | NVV SatyanarayanaEmployee | Sell | 2.0K | ₹9.6L | 466.00 | 21.1K → 19.0K | 0.02%-0.00 pp | 7(2)told 17 Sept 2026 |
| 21 Sept 2026 | NVV SatyanarayanaEmployee | Sell | 1.0K | ₹4.8L | 480.50 | 19.0K → 18.0K | 0.01%-0.00 pp | 7(2)told 17 Sept 2026 |
| 24 Aug 2026 | N. Srilakshmi PadminiRelative | Buy | 3.0K | ₹10.7L | 356.07 | 41.1K → 44.1K | 0.04%+0.00 pp | 7(2)told 21 Aug 2026 |
| 2 Jun 2026 | P. Deepthi SriRelative | Sell | 5.0K | ₹15.8L | 316.00 | 8.9K → 3.9K | 0.00%0.00 pp | 7(2)told 2 Jun 2026 |
| 16 Mar 2026 | P. ManideepOther | Sell | 2.5K | ₹10.1L | 404.40 | 25.9K → 23.4K | 0.02%-0.00 pp | 7(2)told 12 Mar 2026 |
| 28 Feb 2026 | P. Srinivasa RaoEmployee | Sell | 3.0K | ₹11.9L | 395.16 | 3.0K → 28 | 0.00%0.00 pp | 7(2)told 28 Feb 2026 |
| 28 Feb 2026 | P. Srinivasa RaoEmployee | Sell | 2.0K | ₹7.8L | 389.89 | 5.0K → 3.0K | 0.00%0.00 pp | 7(2)told 28 Feb 2026 |
| 28 Feb 2026 | G. Suresh KumarDirector | Sell | 5.0K | ₹19.8L | 395.63 | 15.0K → 10.0K | 0.01%-0.00 pp | 7(2)told 28 Feb 2026 |
| 24 Feb 2026 | G. Suresh KumarDirector | Sell | 1.0K | ₹3.7L | 372.90 | 16.0K → 15.0K | 0.02%-0.00 pp | 7(2)told 23 Feb 2026 |
| 19 Feb 2026 | G. Suresh KumarDirector | Sell | 1.1K | ₹4.1L | 369.80 | 17.1K → 16.0K | 0.02%-0.00 pp | 7(2)told 19 Feb 2026 |
| 28 Nov 2025 | G. Suresh KumarDirector | Sell | 3.0K | ₹9.0L | 298.50 | 20.1K → 17.1K | 0.02%-0.00 pp | 7(2)told 28 Nov 2025 |
| 21 Jun 2023 | TVT INFRACON LLPPromoter | Buy | 20.0K | ₹18.8L | 93.77 | — → 20.0K | 0.02% | 7(2)told 21 Jun 2023 |
| 21 Dec 2020 | Krishna Chaitanya PotluriOther | Sell | 11.3K | ₹12.2L | 108.24 | 11.3K → — | 0.00% | 7(2)told 19 Dec 2020 |
| 26 Nov 2020 | Sudeepthi GopineediPromoter | Sell | 4.05L | ₹3.4Cr | 83.95 | 17.50L → 13.45L | 1.59%-0.48 pp | 7(2)told 25 Nov 2020 |
| 26 Nov 2020 | TVVSN Murthy - HUFPromoter | Sell | 33.95L | ₹28.1Cr | 82.68 | 39.81L → 5.86L | 0.69%-4.00 pp | 7(2)told 25 Nov 2020 |
| 26 Nov 2020 | Potluri Laboratories Private LimitedPromoter | Buy | 4.66L | ₹3.9Cr | 83.95 | 6.54L → 11.20L | 1.32%+0.55 pp | 7(2)told 25 Nov 2020 |
| 26 Nov 2020 | POTLURI INFRA PROJECTS LLPPromoter | Buy | 1.34L | ₹1.1Cr | 84.00 | 59.70L → 61.04L | 7.21%+0.16 pp | 7(2)told 25 Nov 2020 |
| 26 Nov 2020 | Vamsi Krishna PotluriPromoter | Buy | 32.00L | ₹26.4Cr | 82.60 | 48.11L → 80.11L | 9.46%+3.78 pp | 7(2)told 25 Nov 2020 |
| 19 Aug 2020 | Ramesh Babu PotluriKMP | Sell | 4.22L | ₹3.9Cr | 93.45 | 1.45Cr → 1.41Cr | 16.64%-0.50 pp | 7(2)told 18 Aug 2020 |
| 19 Aug 2020 | Potluri Laboratories Private LimitedPromoter | Buy | 4.22L | ₹3.9Cr | 93.45 | 2.32L → 6.54L | 0.77%+0.50 pp | 7(2)told 18 Aug 2020 |
| 11 Mar 2020 | Hima Bindu PotluriPromoter | Buy | 10.25L | ₹3.7Cr | 36.57 | 1.24Cr → 1.34Cr | 15.83%+1.21 pp | 7(2)told 7 Mar 2020 |
| 11 Mar 2020 | Vamsi Krishna PotluriRelative | Buy | 27.60L | ₹10.0Cr | 36.25 | 20.51L → 48.11L | 5.68%+3.26 pp | 7(2)told 7 Mar 2020 |
| 11 Mar 2020 | TVVSN MurthyPromoter | Sell | 27.60L | ₹10.0Cr | 36.25 | 82.27L → 54.67L | 6.46%-3.26 pp | 7(2)told 7 Mar 2020 |
| 11 Mar 2020 | T.AnnapurnaPromoter | Sell | 10.25L | ₹3.7Cr | 36.47 | 43.90L → 33.65L | 3.98%-1.21 pp | 7(2)told 7 Mar 2020 |
| 20 Jun 2017 | Potluri laboratories Private LimitedPromoter | Buy | 2.25L | ₹1.9Cr | 83.15 | 7.4K → 2.32L | 0.27%+0.26 pp | 7(2)told 20 Jun 2017 |
| 20 Jun 2017 | Potluri Infra Projects LLPPromoter | Buy | 1.10L | ₹91.4L | 83.05 | 58.60L → 59.70L | 7.05%+0.13 pp | 7(2)told 20 Jun 2017 |
| 1 Oct 2016 | RAMESH BABU POTLURIPromoter | Buy | 31.50L | ₹29.8Cr | 94.60 | 1.14Cr → 1.45Cr | 17.14%+3.72 pp | 7(2)told 30 Sept 2016 |
| 27 May 2016 | N Durga PrasadEmployee | Buy | 14.9K | ₹14.0L | 94.09 | 2.35L → 2.50L | 0.30%+0.02 pp | 7(2)told 26 May 2016 |
| 16 May 2016 | N Durga PrasadEmployee | Sell | 15.0K | ₹14.6L | 97.33 | 2.50L → 2.35L | 0.28%-0.02 pp | 7(2)told 13 May 2016 |
| 25 Feb 2016 | SEETA RAMA BRAHMAM POTLURUEmployee | Buy | 6.5K | ₹6.3L | 97.79 | 90.7K → 97.1K | 0.12%+0.01 pp | 7(2)told 25 Feb 2016 |
| 9 Feb 2016 | SEETA RAMA BRAHMAM POTLURUEmployee | Buy | 25.1K | ₹25.2L | 100.38 | 65.5K → 90.7K | 0.11%+0.03 pp | 7(2)told 8 Feb 2016 |
| 4 Dec 2015 | Potluri Laboratories Private LimitedPromoter | Sell | 93.0K | ₹8.5Cr | 916.10 | 93.7K → 742 | 0.01%-1.10 pp | 7(2)told 2 Dec 2015 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 11 Sept 2026
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 11 Sept 2026 | Sell · bulk | MICROCURVES TRADING PRIVATE LIMITED | 5.47L | 454.45 | ₹24.8Cr |
| 11 Sept 2026 | Buy · bulk | MICROCURVES TRADING PRIVATE LIMITED | 5.47L | 454.34 | ₹24.8Cr |
| 26 Nov 2025 | Sell · bulk | MUSIGMA SECURITIES | 5.02L | 317.44 | ₹15.9Cr |
| 26 Nov 2025 | Buy · bulk | MUSIGMA SECURITIES | 5.02L | 317.12 | ₹15.9Cr |
| 11 Sept 2025 | Sell · bulk | MUSIGMA SECURITIES | 7.19L | 303.35 | ₹21.8Cr |
| 11 Sept 2025 | Buy · bulk | MUSIGMA SECURITIES | 7.19L | 302.98 | ₹21.8Cr |
| 11 Sept 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.80L | 298.91 | ₹20.3Cr |
| 11 Sept 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.80L | 298.44 | ₹20.3Cr |
| 11 Sept 2025 | Sell · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 6.57L | 302.79 | ₹19.9Cr |
| 11 Sept 2025 | Buy · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 6.57L | 302.55 | ₹19.9Cr |
| 11 Sept 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.58L | 378.38 | ₹24.9Cr |
| 11 Sept 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 6.58L | 377.83 | ₹24.9Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to SMSPHARMA.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 161.5 | 245.8 | 164.5 | 196.7 | 173.4 | 248.2 | 196.0 | 242.4 | 210.4 | 237.9 | 207.0 | 316.1 | |
| Other income | 1.5 | 1.6 | 1.4 | 1.3 | 2.1 | 1.4 | 0.6 | 1.4 | 3.8 | 2.6 | 1.7 | 1.3 | |
| Total income | 163.0 | 247.4 | 165.8 | 198.1 | 175.5 | 249.6 | 196.6 | 243.9 | 214.2 | 240.5 | 208.7 | 317.4 | |
| Total expenses | 146.4 | 225.7 | 144.0 | 178.5 | 153.0 | 221.1 | 172.3 | 209.8 | 183.0 | 213.5 | 181.5 | 264.6 | |
| └ Finance costs | 6.0 | 5.6 | 4.7 | 4.6 | 4.2 | 5.1 | 5.8 | 5.7 | 6.2 | 5.3 | 5.5 | 5.7 | |
| └ Depreciation | 8.0 | 7.9 | 8.4 | 8.6 | 8.7 | 8.6 | 9.8 | 10.0 | 10.0 | 10.1 | 10.0 | 10.4 | |
| Profit before tax | 16.5 | 21.7 | 21.8 | 19.5 | 22.4 | 28.5 | 24.4 | 34.0 | 31.2 | 27.1 | 27.2 | 52.8 | |
| Tax expense | 4.2 | 5.7 | 5.5 | 5.7 | 5.4 | 8.4 | 5.7 | 8.9 | 8.0 | 6.1 | 7.0 | 13.2 | |
| Net profit | 11.5 | 17.3 | 16.5 | 14.1 | 18.2 | 20.3 | 20.5 | 25.3 | 23.5 | 32.7 | 20.9 | 39.9 | |
| EPS | 1.36 | 2.04 | 1.95 | 1.69 | 2.15 | 2.40 | 2.31 | 2.84 | 2.59 | 3.58 | 2.23 | 4.26 | |
| Net margin | 7.11% | 7.03% | 10.02% | 7.17% | 10.52% | 8.18% | 10.45% | 10.44% | 11.15% | 13.75% | 10.10% | 12.61% | |
| PBT margin | 10.23% | 8.84% | 13.27% | 9.93% | 12.94% | 11.49% | 12.43% | 14.04% | 14.81% | 11.38% | 13.14% | 16.71% | |
| Tax rate | 25.63% | 26.15% | 24.99% | 29.07% | 23.89% | 29.60% | 23.20% | 26.18% | 25.58% | 22.55% | 25.75% | 25.08% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 879.6 | 977.1 | 1,034.1 | 1,134.7 | 1,152.7 | 1,276.5 | 1,362.4 | 1,460.6 | |
| Current assets | 410.6 | 500.3 | 533.9 | 581.9 | 554.5 | 661.1 | 638.0 | 685.7 | |
| └ Cash & equivalents | 7.4 | 32.8 | 36.0 | 8.9 | 41.4 | 99.5 | 45.9 | 36.1 | |
| └ Other bank balances | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| └ Current investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Trade receivables | 148.3 | 154.4 | 236.2 | 213.4 | 203.2 | 221.4 | 215.9 | 243.3 | |
| └ Inventories | 223.5 | 277.4 | 233.7 | 315.3 | 284.7 | 317.5 | 351.2 | 377.7 | |
| Total equity | 460.5 | 479.0 | 536.3 | 563.5 | 639.6 | 729.3 | 785.8 | 842.7 | |
| └ Attributable to owners | 460.5 | 479.0 | 536.3 | 563.5 | 639.6 | 729.3 | 785.8 | 842.7 | |
| └ Non-controlling interest | 0.0 | 0.0 | — | — | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Share capital | 8.5 | 8.5 | 8.5 | 8.5 | 8.9 | 9.4 | 9.4 | 9.4 | |
| Borrowings | 252.5 | 275.6 | 280.2 | 285.2 | 310.8 | 324.3 | 365.0 | 349.5 | |
| └ Current | 131.4 | 161.9 | 158.1 | 134.6 | 171.4 | 203.0 | 193.4 | 196.3 | |
| └ Non-current | 121.1 | 113.7 | 122.1 | 150.6 | 139.4 | 121.3 | 171.6 | 153.1 | |
| Trade payables | 113.1 | 159.2 | 151.3 | 215.1 | 113.9 | 139.7 | 120.4 | 170.5 | |
| Current liabilities | 254.9 | 341.4 | 331.7 | 375.4 | 324.4 | 375.2 | 353.0 | 411.2 | |
| Total liabilities | 419.1 | 498.1 | 497.8 | 571.2 | 513.0 | 547.1 | 576.6 | 618.0 | |
| Net debt | 245.0 | 242.7 | 244.0 | 276.1 | 269.2 | 224.6 | 319.0 | 313.2 | |
| Debt / equity | 0.55 | 0.58 | 0.52 | 0.51 | 0.49 | 0.44 | 0.46 | 0.41 | |
| Current ratio | 1.61 | 1.47 | 1.61 | 1.55 | 1.71 | 1.76 | 1.81 | 1.67 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 22.5 | 33.5 | 50.1 | 48.7 | 81.7 | 42.3 | 59.2 | 105.8 | |
| └ Capex | (29.9) | (19.9) | (52.2) | (71.2) | (123.4) | (29.7) | (130.6) | (85.9) | |
| Free cash flow | (7.5) | 13.6 | (2.0) | (22.5) | (41.7) | 12.7 | (71.3) | 19.9 | |
| Investing cash flow | (29.7) | (19.8) | (52.1) | (71.4) | (123.4) | (30.5) | (130.8) | (85.4) | |
| Financing cash flow | (32.0) | 11.8 | 30.7 | (4.4) | 47.1 | 46.3 | 76.0 | (30.1) | |
| └ Dividends paid | (2.5) | 0.0 | (2.5) | 0.0 | (3.4) | (3.5) | (3.5) | (3.7) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | (39.2) | 25.5 | 28.7 | (27.1) | 5.4 | 58.1 | 4.5 | (9.8) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →SMSPHARMA at a glance
- SMSPHARMA closed at ₹473.25 on 20 Nov 2026, -1.68% on the day, +65.9% over one year, 11.5% below its 52-week high of ₹535.
- Delivery was 54.0% of traded quantity on 20 Nov 2026, the 36th percentile of its own 3,527 sessions with a reading (20-session average 40.5%, 1-year average 42.2%).
- Market capitalisation is ₹4,432 crore at a trailing P/E of 37.8 (trailing EPS ₹12.52).
- Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹316 crore (+30.4% year on year), net profit ₹40 crore (+57.4%); the price moved -1.7% on the first session after.
- Promoters held 68.07% at 30 Sept 2026, unchanged on the previous filing, with 17.99% of promoter shares pledged.
- Q3 FY27 results are expected between 7 Feb 2027 and 12 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE